| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |